SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-021982
Filing Date
2011-04-14
Accepted
2011-04-14 15:38:48
Documents
5
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v218522_10k.htm 10-K 894808
2 v218522_ex31-1.htm EX-31.1 15983
3 v218522_ex31-2.htm EX-31.2 15986
4 v218522_ex32-1.htm EX-32.1 5778
5 v218522_ex32-2.htm EX-32.2 5785
  Complete submission text file 0001144204-11-021982.txt   939466
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53127 | Film No.: 11759664
SIC: 4731 Arrangement of Transportation of Freight & Cargo